Here, we tested the hypothesis that CB2 plays a protective role in suppressing tumorigenesis using a systemic CB2 knockout (CB2−/−) model and well-established colon cancer models in immunocompetent mice and examined the association between the CNR2 gene variants and colon cancer in a human population. The gene discussed is CNR2; the disease is malignant colon neoplasm.